Biomirex Inc. is a drug discovery company based in Watertown, MA, specializing in the development of antibody-based therapeutics for complex membrane proteins. Their core technology, developed at Harvard Medical School, allows for the display of these proteins in their native conformation, enabling the isolation of fully human antibodies for potential therapeutic use.
With a focus on G-Protein Coupled Receptors, amino acid and drug transporters, and ion channels, Biomirex's target display platforms extract integral membrane proteins in a highly purified form, amplifying the signal for recognition within a phage display system or as an immunogen.
Generated from the website